Variable | Multivariable model | P-value |
---|---|---|
OR (95% CI) | ||
Income level 2020 (Feb), per increase 5% (model 1) | 1.01 (0.99, 1.03) | 0.472 |
Income level 2020 (Feb) (model 2) | ||
Q4 (Highest) | 1 | |
Q3 | 1.25 (0.80, 1.94) | 0.322 |
Q2 | 1.18 (0.71, 1.96) | 0.526 |
Q1 (Lowest) | 1.23 (0.83, 1.80) | 0.300 |
unknown | 0.68 (0.17, 2.71) | 0.586 |
AGE, 10 year increase | 3.23 (2.70, 3.86) | < 0.001 |
Sex, male | 2.48 (1.81,3.41) | < 0.001 |
Residence at Februrary, 2020 | ||
Seoul | 1 | |
Gyeonggi-do | 2.86 (0.79, 10.36) | 0.109 |
Daegu | 3.39 (0.80, 14.33) | 0.096 |
Gyeongsangbuk-do | 2.49 (0.66, 9.33) | 0.176 |
Other area | 2.41 (0.60, 9.72) | 0.216 |
Grade of disability | ||
No disability | 1 | |
Severe | 2.82 (1.68, 4.73) | < 0.001 |
Mild to moderate | 0.87 (0.55, 1.38) | 0.557 |
Charlson comorbidity index, 1 point (model 1) | 1.27 (1.04, 1.55) | 0.017 |
Peripheral vascular disease | 1.13 (0.76, 1.69) | 0.549 |
Renal disease | 1.57 (0.93, 2.64) | 0.093 |
Rheumatic disease | 0.39 (0.18, 0.84) | 0.016 |
Dementia | 1.87 (1.27, 2.73) | 0.001 |
Peptic ulcer disease | 1.10 (0.76, 1.60) | 0.620 |
DM without chronic complication | 1.74 (1.13, 2.69) | 0.013 |
Hemiplegia or paraplegia | 1.59 (0.83, 3.07) | 0.163 |
Moderate or severe liver disease | 3.50 (0.87, 14.12) | 0.078 |
Mild liver disease | 0.78 (0.56, 1.09) | 0.150 |
Chronic pulmonary disease | 1.69 (1.23, 2.33) | 0.001 |
DM with chronic complication | 1.74 (1.13, 2.69) | 0.013 |
Cerebrovascular disease | 0.73 (0.48, 1.10) | 0.131 |
Congestive heart failure | 1.89 (1.35, 2.66) | < 0.001 |
Myocardial infarction | 0.96 (0.56, 1.64) | 0.879 |
Malignancy | 1.02 (0.73, 1.42) | 0.905 |
Metastatic solid tumor | 1.96 (1.26, 3.05) | 0.003 |
AIDS/HIV | 1.19 (0.09, 15.64) | 0.893 |